https://globenewswire.com/news-release/2014/10/29/677901/10105274/en/U-S-FDA-Grants-Fast-Track-Designation-to-Novavax-H7N9-Influenza-Virus-Like-Particle-Vaccine-Candidate-Adjuvanted-With-Matrix-M-TM.html
Posted by Rob LW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment